** Shares in Sanofi SASY.PA drop around 3% as U.S. FDA appointed on Tuesday the agency critic Vinay Prasad as top vaccine official
** Prasad was appointed the director of the Center for Biologics Evaluation and Research (CBER), overseeing regulation of drugs, including vaccines
** Bernstein's analyst Florent Cespedes says Prasad's appointment put pharmaceutical stocks under pressure with vaccine companies being more impacted
** Shares in Sanofi, which is one of the world's largest vaccine makers by sales, trade at the bottom of France's blue-chip CAC 40 Index .FCHI
** They will see their worst day in almost a month, if losses hold
(Reporting by Michal Aleksandrowicz)
((michal.aleksandrowicz@tr.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。